Resultados de procura - Peter Reichardt
- Mostrando 1 - 20 Resultados de 80
- Go to Next Page
-
1
The treatment of uterine sarcomas por Peter Reichardt
Publicado 2012Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Monitoring of Tumor Cell Purging After Highly Efficient Immunomagnetic Selection of CD34 Cells From Leukapheresis Products in Breast Cancer Patients: Comparison of Immunocytochemic... por Markus Y. Mapara, I. Körner, Martin Hildebrandt, Ralf C. Bargou, Dorothea Krahl, Peter Reichardt, Bernd Dörken
Publicado 1997Artigo -
13
Diffusion‐weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft‐tissue sarcomas por Oliver Dudeck, M Zeile, Daniel Pink, Maciej Pech, Per‐Ulf Tunn, Peter Reichardt, Wolfgang Ludwig, Bernd Hamm
Publicado 2008Artigo -
14
Three-Dimensional Patient-Derived In Vitro Sarcoma Models: Promising Tools for Improving Clinical Tumor Management por Manuela Gaebler, Alessandra Silvestri, Johannes Haybaeck, Peter Reichardt, Caitlin D. Lowery, Louis F. Stancato, Gabriele Zybarth, Christian Regenbrecht
Publicado 2017Revisão -
15
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies por Zoe Waibler, Linda Y. Sender, Camilla Merten, Roland Hartig, Stefanie Kliche, Matthias Gunzer, Peter Reichardt, Ulrich Kalinke, Burkhart Schraven
Publicado 2008Artigo -
16
-
17
Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis por Daniel Pink, Stephan Richter, Sebastian Gerdes, Dimosthenis Andreou, Per‐Ulf Tunn, Christoph Busemann, Gerhard Ehninger, Peter Reichardt, Markus K. Schuler
Publicado 2014Artigo -
18
Docetaxel and Continuous-Infusion Fluorouracil Versus Epirubicin, Cisplatin, and Fluorouracil for Advanced Gastric Adenocarcinoma: A Randomized Phase II Study por Peter Thuss‐Patience, Albrecht Kretzschmar, Michael Repp, D. Kingreen, Dirk Hennesser, S. Micheel, Daniel Pink, Christian W. Scholz, Bernd Dörken, Peter Reichardt
Publicado 2005Artigo -
19
Control of Uterine Microenvironment by Foxp3+ Cells Facilitates Embryo Implantation por Ana Teles, Anne Schumacher, Marie-Cristine Kühnle, Nadja Linzke, Catharina Thuere, Peter Reichardt, Carlos E. Tadokoro, Günter J. Hämmerling, Ana Claudia Zenclussen
Publicado 2013Artigo -
20
A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors por Patrick Schöffski, Peter Reichardt, Jean‐Yves Blay, Herlinde Dumez, Jeffrey A. Morgan, Isabelle Ray‐Coquard, Norbert Hollaender, Annette Jappe, George D. Demetri
Publicado 2010Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Oncology
Pathology
Cancer
Stromal cell
Surgery
Chemotherapy
GiST
Imatinib
Myeloid leukemia
Gastroenterology
Imatinib mesylate
Clinical trial
Sarcoma
Clinical endpoint
Adverse effect
Stromal tumor
Biology
Radiology
Randomized controlled trial
Breast cancer
Confidence interval
Phases of clinical research
Sunitinib
Environmental health
Family medicine
Hazard ratio
PDGFRA
Population